Oncology
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
Abiraterone Acetate tablets 250mg price in India
Abiraterone acetate for the treatment of castrate-refractory prostate cancer | Aging Health
The accidental discovery of the world's most expensive prebiotic? | Microbiology Community
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
202379Orig1s000
2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study - ScienceDirect
Mechanism of action of abiraterone and antiandrogens. Abbreviations: A,... | Download Scientific Diagram
Mechanism of Action of Abiraterone Acetate 7 | Download Scientific Diagram
Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Zytiga (Abiraterone J&J) for Treatment of Prostate Cancer (mCRPC) - Prostate Cancer Specialists in NYC
TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer - Qin - 2018 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Abiraterone | Uses, Brand Names, Mechanism Of Action
AusPAR Attachment 1: Product Information for Zytiga (abiraterone acetate)
Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
